Methylphenidate Hydrochloride 27 mg/1 (Methylphenidate Hydrochloride TABLET, EXTENDED RELEASE) 27 mg/1

Methylphenidate Hydrochloride 27 mg is an extended-release tablet used for attention deficit hyperactivity disorder (ADHD) management. This medication helps improve focus and reduce impulsivity.

Strength

27 mg/1

Pack Size

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-953-01)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methylphenidate Hydrochloride is primarily used to manage symptoms of ADHD in both children and adults. It works by affecting certain chemicals in the brain that may be unbalanced in people with ADHD. This medication is often prescribed as part of a treatment plan that includes psychological, educational, and social measures.

Side Effects

Common effects of Methylphenidate Hydrochloride may include decreased appetite, trouble sleeping, and dry mouth. Some users may experience headaches or stomach pain. These effects vary and are not experienced by everyone.

Precautions & Warnings

Methylphenidate Hydrochloride should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication should be stored securely to prevent misuse. Consult a healthcare provider before use if you have any pre-existing conditions.

Avoid Interactions

Methylphenidate Hydrochloride may interact with certain medications, including antidepressants, blood pressure medications, and seizure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Methylphenidate Hydrochloride is used to manage symptoms of ADHD, helping to improve focus and reduce impulsivity.

Methylphenidate Hydrochloride is typically taken orally, usually in the morning. Follow the specific instructions provided by your healthcare provider.

Common side effects may include decreased appetite, trouble sleeping, and dry mouth. Some users may experience headaches or stomach pain.

Methylphenidate Hydrochloride may interact with certain medications. Always consult your healthcare provider before combining it with other drugs.

Long-term use of Methylphenidate Hydrochloride should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.